ArcticZymes is attending ASGCT 25th Annual Meeting

ArcticZymes Technologies is attending the ASGCT 25th Annual Meeting in Washington, D.C. from – May 16-19. Mr. Scott Frayo is looking forward to meeting you at booth 241 for a discussion on how our SAN HQ, SAN HQ 2.0 and M-SAN HQ can improve the efficiency of your viral bioprocessing process. Our salt active nuclease (SAN) enzymes have been validated …

Q1 2022 report and presentation

Tromsø, Norway, 28th April 2022 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 49.2 million (40.9) and an EBITDA of NOK 27.9 million (25.8) for the first quarter of 2022. Highlights from Q1 2022 ArcticZymes Technologies (AZT) had Q1 sales of NOK 49.2 million growing by 21% (Q1 2021: NOK 40.9 million) Positive EBITDA of NOK 27.9 million (Q1 …

ArcticZymes Technologies attending 32nd ECCMID

ArcticZymes Technologies will attend the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will take place from the 23rd to 26th of April in Lisbon, Portugal. Our team is looking forward to meeting you at booth 2-11.1 located in Pavilion 3 to discuss your needs and share the latest development on our enzymes!